Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation. - Wikidata - awgldk - TriplyDB

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

http://www.wikidata.org/entity/Q34481890

about

Plasma proteomic profiling in HIV-1 infected methamphetamine abusers Elucidating protein inter- and intramolecular interacting domains using chemical cross-linking and matrix-assisted laser desorption ionization-time of flight/time of flight mass spectrometry Chromatin immunoprecipitation for human monocyte derived macrophages Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.Plasma gelsolin protects HIV-1 gp120-induced neuronal injury via voltage-gated K+ channel Kv2.1.Gelsolin: the tail of a molecular gymnast.Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target Plasma gelsolin promotes re-epithelialization

P2860

Q28480898-5D0A2919-9AA4-43AA-AFD3-3EB54BE3AB86 Q34121170-A94851DF-5D67-43B4-B9CE-7E3801B7BF7E Q34714919-ADBDA992-BF61-404A-9D1E-958B602A750D Q36780412-32E45163-4DB6-46A5-8A7B-A7A6A37AA52C Q37524897-3C45D983-6402-4CA1-9FB3-8AE3C773B271 Q38113172-261C7C64-B2E9-410D-B880-01D7C0A9476A Q58702505-44DC9399-A7F8-4D22-9C14-5416D041D586 Q58769074-E9D14C92-EB59-4842-9130-D340AAF1BF59

P2860

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

http://www.wikidata.org/entity/Q34481890

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@ast

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@en

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@nl

type

label

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@ast

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@en

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@nl

prefLabel

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@ast

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@en

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@nl

P1433

Q34481890-D64F248E-D8C5-4E9B-A911-B1098A1756E3

P1476

Q34481890-ACB9426E-D295-43B0-A17F-4B7071EECFBD

P2093

Q34481890-09ABC43A-BA66-459D-B83A-FE519EC4E618

Q34481890-2A63C249-B47D-4D5C-8924-F7F4CED5D862

Q34481890-3CAB9715-C0BE-4266-828E-414E3C5E01FF

Q34481890-DF887B40-2101-495B-BA29-CFAC3C710CAE

P2860

Q34481890-0648A6A8-7146-49DB-9749-640D9D58D603

Q34481890-0B91A8EF-E73F-454A-A85B-D956F48F3AAD

Q34481890-14351ABA-B0FC-48A1-B855-721ABBF74DFF

Q34481890-14E3DDF8-5D72-4CF7-8744-21077EDF32A0

Q34481890-1FCF77CD-C026-4616-AAF4-A43628AA4F18

Q34481890-307BBACB-CF8B-4931-91ED-88B1684D7765

Q34481890-5117119A-CBE4-4EFA-9E75-CF87E2026C34

Q34481890-679E07D7-FC1C-46D1-B841-7908EC146359

Q34481890-7A1254F1-A128-464D-978D-01955401DF02

Q34481890-7BF8A93C-E3CC-4AD1-8759-009C5342C107

P2888

Q34481890-7150570C-0CB6-4002-82BF-FC2069707AEE

P304

Q34481890-1EBA0FBC-87C4-4790-A168-665E3DBC2E70

P31

Q34481890-FF1D9ECA-4226-47ED-9C0B-46C4AE9F94D7

P356

Q34481890-FB77A14B-1E3F-4457-A237-79053348C112

P478

Q34481890-94617EAC-549A-41A4-AEF0-B5DCF1E12417

P577

Q34481890-130BAC63-2CC6-4198-9FEF-E52600FC6A4D

P5875

Q34481890-36245C90-CFEC-4407-AF46-B627F979966D

P6179

Q34481890-1D504718-8392-431F-AA0F-58B8054D7EDD

P698

Q34481890-976AF842-ACF0-46BF-9274-DF1B6A97757C

P921

Q34481890-1BF6E0A6-D6F9-4D68-8045-A45EEF630000

Q34481890-510CFFCE-77E5-44FC-A61E-CED946FA726E

P932

Q34481890-634419AB-F337-45BE-8D1A-942B8A1A6547

P356

1479-5876-8-137

P1433

Journal of Translational Medicine

P1476

Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

@en

P2093

Gwënaël Pottiez

http://www.w3.org/2001/XMLSchema#string

Jayme Wiederin

http://www.w3.org/2001/XMLSchema#string

Nicole Haverland

http://www.w3.org/2001/XMLSchema#string

Pawel Ciborowski

http://www.w3.org/2001/XMLSchema#string

P2860

The human plasma proteome: history, character, and diagnostic prospects

Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry

Coherent pipeline for biomarker discovery using mass spectrometry and bioinformatics.

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.

Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein.

Biomarker discovery and clinical proteomics.

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins.

The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum.

Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.

P2888

1479-5876-8-137

P304

137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-8-137

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49696478

http://www.w3.org/2001/XMLSchema#string

P6179

1000778651

http://www.w3.org/2001/XMLSchema#string

P698

21171974

http://www.w3.org/2001/XMLSchema#string

P921

P932

3019187

http://www.w3.org/2001/XMLSchema#string